Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Sarcoma 1Dermatologic 1

Conditions

Small Cell Lung Carcinoma 1Melanoma 1Medulloblastoma 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Neoplasms 1Brain Neoplasms 1Basal Cell Nevus Syndrome 1

Interventions

sonidegib 2Etoposide 2Carboplatin 2tipifarnib 1merphos 1entinostat 1carboxyamido-triazole 1bempegaldesleukin 1Vincristine 1Thrombopoietin 1Thalidomide 1Paclitaxel 1Oxaliplatin 1Nivolumab 1NVP-LEQ506 1Methotrexate 1Mental Status and Dementia Tests 1LY2940680 1Irinotecan 1Immunologic Techniques 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Fentanyl 1Docetaxel 1Cyclophosphamide 190Y-octreotide, DOTA-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Medulloblastoma × Mental Status and Dementia Tests × Dermatologic × Clear all
NCT02017964 2023-01-09

Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma

Children's Oncology Group

Phase 2 Completed
26 enrolled 14 charts
CNSDermatologic

Basal Cell Nevus Syndrome, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡